Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia

NCT00824512 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Friedreich Ataxia

Interventions

DRUG: EGb 761 120 mg
DRUG: Placebo

Sponsor

Ipsen